AlphaVest Acquisition Corp Ordinary Shares (NASDAQ:ATMV) — Market Cap & Net Worth
Market Cap & Net Worth: AlphaVest Acquisition Corp Ordinary Shares (ATMV)
AlphaVest Acquisition Corp Ordinary Shares (NASDAQ:ATMV) has a market capitalization of $16.80 Million ($16.80 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25734 globally and #5413 in its home market, demonstrating a -13.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AlphaVest Acquisition Corp Ordinary Shares's stock price $6.84 by its total outstanding shares 2455548 (2.46 Million). Also see total assets of AlphaVest Acquisition Corp Ordinary Shar for a full breakdown of the balance sheet.
AlphaVest Acquisition Corp Ordinary Shares Market Cap History: 2023 to 2025
AlphaVest Acquisition Corp Ordinary Shares's market capitalization history from 2023 to 2025. Data shows change from $26.30 Million to $16.80 Million (-12.67% CAGR). Also see ATMV operating cash flow for how efficiently the company converts equity into cash flow.
Index Memberships
AlphaVest Acquisition Corp Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2380 of 3165 |
Weight: AlphaVest Acquisition Corp Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AlphaVest Acquisition Corp Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AlphaVest Acquisition Corp Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ATMV share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ATMV by Market Capitalization
Companies near AlphaVest Acquisition Corp Ordinary Shares in the global market cap rankings as of September 18, 2026. Review AlphaVest Acquisition Corp Ordinary Shar tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to AlphaVest Acquisition Corp Ordinary Shares by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6471 globally with a market cap of $1.84 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10992 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11465 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11869 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6471 | Twenty One Capital, Inc. | NYSE:XXI | $1.84 Billion | $5.32 |
| #10992 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.16 |
| #11465 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11869 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
AlphaVest Acquisition Corp Ordinary Shares Historical Marketcap From 2023 to 2025
Between 2023 and today, AlphaVest Acquisition Corp Ordinary Shares's market cap moved from $26.30 Million to $ 16.80 Million, with a yearly change of -12.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $16.80 Million | -39.74% |
| 2024 | $27.87 Million | +5.98% |
| 2023 | $26.30 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of AlphaVest Acquisition Corp Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.80 Million USD |
| MoneyControl | $16.80 Million USD |
| MarketWatch | $16.80 Million USD |
| marketcap.company | $16.80 Million USD |
| Reuters | $16.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AlphaVest Acquisition Corp Ordinary Shares
AlphaVest Acquisition Corp does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2022 and is based in New York, New York.